Economy
Cryoviva and Reviva Cell Donate 50 Million Baht to Chulalongkorn Medical Research
Cryoviva (Thailand) and Reviva Cell (Thailand) have pledged 50 million baht to support future medical research at Chulalongkorn University’s Faculty of Medicine.
On September 1, 2026, Prachachat Business reported that Cryoviva (Thailand) and Reviva Cell (Thailand) announced a joint donation of 50 million baht to the Faculty of Medicine at Chulalongkorn University. The funds are designated for the 'Research and Development for Future Medicine' fund managed by the Faculty of Medicine Foundation.
According to the report, this contribution aims to advance medical research and innovation within Thailand, specifically focusing on the development of future medical technologies. By supporting one of the country's leading medical institutions, the companies intend to bolster the local health economy and enhance research capabilities.
For residents and expatriates in Thailand, this development highlights a continued investment in the nation's medical infrastructure. While the donation marks a significant financial commitment to academic research, the specific medical projects or clinical applications that will be prioritized using these funds have not yet been detailed. It remains to be seen how this research will translate into tangible healthcare advancements or new treatment options for the public. As this is an ongoing academic initiative, further updates regarding the specific research outcomes will likely be provided by the university as the projects progress.